Lakmet 25mg Tablet XL contains Metoprolol Succinate, a cardioselective beta-1 adrenergic receptor blocker used primarily in the management of hypertension, angina pectoris, and heart failure. This extended-release formulation allows for once-daily dosing, providing sustained therapeutic effects and improved patient compliance. Metoprolol Succinate works by selectively inhibiting beta-1 receptors in the heart, leading to a decrease in heart rate, myocardial contractility, and cardiac output, thereby reducing blood pressure and myocardial oxygen demand. It is indicated for the treatment of essential hypertension, stable angina, and as part of the management strategy for chronic heart failure and post-myocardial infarction to improve survival. Lakmet 25mg Tablet XL should be administered under medical supervision, with dosage adjustments based on clinical response and patient tolerance. Common side effects may include fatigue, dizziness, bradycardia, and gastrointestinal disturbances. Caution is advised in patients with asthma, diabetes, or peripheral vascular disease due to potential exacerbation of symptoms. Abrupt discontinuation should be avoided to prevent acute tachycardia or hypertension. Regular monitoring of blood pressure, heart rate, and cardiac function is recommended during therapy to ensure optimal efficacy and safety.